Highlights from the European Respiratory Society virtual meeting by John Gever Several studies caught our eye at the just-concluded European Respiratory Society's virtual annual meeting. Among them: more negative findings for ivermectin as a COVID-19 treatment;...
— Study finds little reason for optimism about long-term outlook By John Gever New studies confirm that fatigue remains the most common feature of so-called long COVID-19, and in a substantial fraction it is the most stubborn. In fact, researchers are finding that a...
June 23, 2021 ~ MedPage Today ~ by John Gever 'Breakthrough' COVID Infections Less Transmissible, English Data Indicate — But variants could be a wild card People who develop so-called breakthrough infections after receiving either the Pfizer-BioNTech or AstraZeneca...